181 related articles for article (PubMed ID: 9210036)
1. Enzyme-linked immunosorbent assay-IgG antibody avidity test for single sample serologic evaluation of measles vaccines.
de Souza VA; Pannuti CS; Sumita LM; de Andrade Júnior HF
J Med Virol; 1997 Jul; 52(3):275-9. PubMed ID: 9210036
[TBL] [Abstract][Full Text] [Related]
2. Poor serologic responses five to seven years after immunization with high and standard titer measles vaccines.
Whittle H; Aaby P; Samb B; Cissé B; Kanteh F; Soumaré M; Jensen H; Bennett J; Simondon F
Pediatr Infect Dis J; 1999 Jan; 18(1):53-7. PubMed ID: 9951981
[TBL] [Abstract][Full Text] [Related]
3. [A seroconversion study of the measles component of the MMR vaccine in adolescents of the town of Sabrosa].
Gonçalves G; Tavares F; de Andrade HR
Acta Med Port; 1998 Dec; 11(12):1079-84. PubMed ID: 10192981
[TBL] [Abstract][Full Text] [Related]
4. Secondary measles vaccine failures identified by measurement of IgG avidity: high occurrence among teenagers vaccinated at a young age.
Paunio M; Hedman K; Davidkin I; Valle M; Heinonen OP; Leinikki P; Salmi A; Peltola H
Epidemiol Infect; 2000 Apr; 124(2):263-71. PubMed ID: 10813152
[TBL] [Abstract][Full Text] [Related]
5. Measles antibody responses after early two dose trials in Guinea-Bissau with Edmonston-Zagreb and Schwarz standard-titre measles vaccine: better antibody increase from booster dose of the Edmonston-Zagreb vaccine.
Garly ML; Balé C; Martins CL; Monteiro M; George E; Kidd M; Dias F; Aaby P; Whittle HC
Vaccine; 2001 Feb; 19(15-16):1951-9. PubMed ID: 11228365
[TBL] [Abstract][Full Text] [Related]
6. [Gelatin particle agglutination (PA) antibody: comparison to neutralizing antibody (NT) and hemagglutination inhibition (HI) antibody and relationship to IgG avidity].
Saika S; Matsunaga T; Ogawa T; Ichinohe S
Kansenshogaku Zasshi; 2008 Jul; 82(4):310-6. PubMed ID: 18697482
[TBL] [Abstract][Full Text] [Related]
7. Identification of primary and secondary measles vaccine failures by measurement of immunoglobulin G avidity in measles cases during the 1997 São Paulo epidemic.
Pannuti CS; Morello RJ; Moraes JC; Curti SP; Afonso AM; Camargo MC; Souza VA
Clin Diagn Lab Immunol; 2004 Jan; 11(1):119-22. PubMed ID: 14715557
[TBL] [Abstract][Full Text] [Related]
8. Immunization of six-month-old infants with different doses of Edmonston-Zagreb and Schwarz measles vaccines.
Markowitz LE; Sepulveda J; Diaz-Ortega JL; Valdespino JL; Albrecht P; Zell ER; Stewart J; Zarate ML; Bernier RH
N Engl J Med; 1990 Mar; 322(9):580-7. PubMed ID: 2304505
[TBL] [Abstract][Full Text] [Related]
9. Maturation of immunoglobulin G avidity after rubella vaccination studied by an enzyme linked immunosorbent assay (avidity-ELISA) and by haemolysis typing.
Hedman K; Hietala J; Tiilikainen A; Hartikainen-Sorri AL; Räihä K; Suni J; Väänänen P; Pietiläinen M
J Med Virol; 1989 Apr; 27(4):293-8. PubMed ID: 2656909
[TBL] [Abstract][Full Text] [Related]
10. Determination of immunity to measles virus in young adults: comparative evaluation of a commercial enzyme immunoassay and the hemagglutination inhibition techniques.
Duvdevani P; Varsano N; Slepon R; Lerman Y; Shohat T; Mendelson E
Clin Diagn Virol; 1996 Oct; 7(1):1-6. PubMed ID: 9077425
[TBL] [Abstract][Full Text] [Related]
11. Measles antibody levels after vaccination with Edmonston-Zagreb and Schwarz measles vaccine at 9 months or at 9 and 18 months of age: a serological study within a randomised trial of different measles vaccines.
Martins C; Garly ML; Bale C; Rodrigues A; Benn CS; Whittle H; Aaby P
Vaccine; 2013 Nov; 31(48):5766-71. PubMed ID: 23994379
[TBL] [Abstract][Full Text] [Related]
12. Successful immunization of infants at 6 months of age with high dose Edmonston-Zagreb measles vaccine. Cite Soleil/JHU Project Team.
Job JS; Halsey NA; Boulos R; Holt E; Farrell D; Albrecht P; Brutus JR; Adrien M; Andre J; Chan E
Pediatr Infect Dis J; 1991 Apr; 10(4):303-11. PubMed ID: 2062626
[TBL] [Abstract][Full Text] [Related]
13. Trials of Edmonston-Zagreb measles vaccine in Guinea-Bissau: serological responses following vaccination with Edmonston-Zagreb strain at 4-8 months versus vaccination with Schwarz strain at 9-12 months of age.
Jensen TG; Whittle H; Mordhorst CH; Pedersen IR; Thaarup J; Poulsen A; Sodemann M; Jakobsen M; Brink L; Gansted U
Vaccine; 1994 Aug; 12(11):1026-31. PubMed ID: 7975843
[TBL] [Abstract][Full Text] [Related]
14. Measles antibody: comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity to and booster effects on the measles virus.
Christenson B; Böttiger M
Vaccine; 1994 Feb; 12(2):129-33. PubMed ID: 8147093
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 infection in Zambian children impairs the development and avidity maturation of measles virus-specific immunoglobulin G after vaccination and infection.
Nair N; Moss WJ; Scott S; Mugala N; Ndhlovu ZM; Lilo K; Ryon JJ; Monze M; Quinn TC; Cousens S; Cutts F; Griffin DE
J Infect Dis; 2009 Oct; 200(7):1031-8. PubMed ID: 19702505
[TBL] [Abstract][Full Text] [Related]
16. Comparison of high titer Edmonston-Zagreb, Biken-CAM and Schwarz measles vaccines in Peruvian infants.
Berry S; Hernandez H; Kanashiro R; Campos M; Azabache V; Gomez G; Gutierrez M; Weirs B; De Quadros C; Halsey N
Pediatr Infect Dis J; 1992 Oct; 11(10):822-7. PubMed ID: 1408479
[TBL] [Abstract][Full Text] [Related]
17. Intradermal administration of measles vaccines.
de Moraes JC; León ME; Souza VA; Pannuti C; Travisanello C; Halsey NA; de Quadros CA
Bull Pan Am Health Organ; 1994 Sep; 28(3):250-5. PubMed ID: 7951368
[TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin G avidity testing in serum and cerebrospinal fluid for analysis of measles virus infection.
Narita M; Yamada S; Matsuzono Y; Itakura O; Togashi T; Kikuta H
Clin Diagn Lab Immunol; 1996 Mar; 3(2):211-5. PubMed ID: 8991638
[TBL] [Abstract][Full Text] [Related]
19. Serological effects of Edmonston-Zagreb, Schwarz, and AIK-C measles vaccine strains given at ages 4-5 or 8-10 months.
Tidjani O; Grunitsky B; Guérin N; Lévy-Bruhl D; Lecam N; Xuereff C; Tatagan K
Lancet; 1989 Dec; 2(8676):1357-60. PubMed ID: 2574304
[TBL] [Abstract][Full Text] [Related]
20. Comparison of plaque reduction neutralisation test (PRNT) and measles virus-specific IgG ELISA for assessing immunogenicity of measles vaccination.
Cohen BJ; Doblas D; Andrews N
Vaccine; 2008 Nov; 26(50):6392-7. PubMed ID: 18834911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
